← Dashboard
Stock
FMS
FRESENIUS MEDICAL CARE AGLatest close $226 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
6
27 funds tracked
Ever held
6
Current + past
New this quarter
0
Exited this quarter
0
Marquee-fund ownership over time
Aug 14, 2024Feb 14, 2025Nov 14, 2025Feb 17, 2026
Now
6
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $18 | $22 | +22% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $18 | $22 | +22% |
| AQR Capital Management re-entered | Q3 2024(8Q snapshot) | 7Q | $18 | $22 | +22% |
| D.E. Shaw re-entered | Q4 2024(8Q snapshot) | 6Q | $21 | $22 | +7% |
| Millennium Management | Q4 2024(8Q snapshot) | 6Q | $21 | $22 | +7% |
| Point72 Asset Management re-entered | Q1 2025(8Q snapshot) | 5Q | $23 | $22 | -2% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Fundamentals
XBRL · FRESENIUS MEDICAL CARE AGAnnual figures sourced directly from FRESENIUS MEDICAL CARE AG's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Net income
$1.11B
FY2013-6% YoY
EPS (diluted)
$3.65
FY2013-6% YoY
Free cash flow(?)
$1.29B
FY2013-6% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Fresenius Medical Care AG — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KFORM 6-KMay 28, 2026
- 6-KFORM 6-KMay 26, 2026
- 6-KFORM 6-KMay 5, 2026
- 6-KFORM 6-KMay 5, 2026
- 6-KFORM 6-KApr 14, 2026
- 6-KFORM 6-KFeb 24, 2026
- 20-FFORM 20-FFeb 24, 2026
- 6-KFORM 6-KFeb 24, 2026
- 6-KFORM 6-KJan 12, 2026
- 6-KFORM 6-KDec 10, 2025
- 6-KFORM 6-KNov 17, 2025
- 6-KFORM 6-KNov 4, 2025
- 6-KFORM 6-KNov 4, 2025
- 6-KFORM 6-KOct 1, 2025
- 6-KFORM 6-KSep 19, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q1 2026 | open | $25 | $22 | -10% |
| D.E. Shaw | Q1 2026 | open | $25 | $22 | -10% |
| Point72 Asset Management | Q4 2025 | open | $23 | $22 | -5% |
| AQR Capital Management | Q1 2025 | open | $23 | $22 | -2% |
| Point72 Asset Management | Q1 2025 | Q3 2025 | $23 | $25 | +9% |
| D.E. Shaw | Q4 2024 | Q1 2025 | $21 | $23 | +10% |
| Millennium Management | Q4 2024 | open | $21 | $22 | +7% |
| Citadel Advisors | Q3 2024 | Q4 2025 | $18 | $23 | +28% |
| Two Sigma Investments | Q3 2024 | open | $18 | $22 | +22% |
| AQR Capital Management | Q3 2024 | Q4 2024 | $18 | $21 | +14% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.